Others

P-12.3.10 - Application of Deep Learning Models to Predict Achievement of PASS at Minimum 2-Year Follow-Up After Primary Hip Arthroscopy

Authors
Speaker
Disclosure
Financial interests: Amplitude, Arthrex, ATI, Breg, DJO Global, Kauffman Foundation, MAKO Surgical, Medacta, Medwest, Orthomerica, Pacira Pharmaceuticals, Stryker Affiliations: American Hip Institute, Hinsdale Orthopaedics, North Shore Surgical Suites,
Presentation Topic
Others
Poster Rating
 | 

Previous ePoster
P-12.3.3 - Prospective Evaluation of Damage Marking Report Software to Predict Osteochondral Allograft Transplantation Graft Area

Next ePosters
P-16.1.6 - Cartilage Cells, Adipose- and Bone Marrow-derived Stem Cells Release miRNA that are Involved in Cartilage Damage-related Pathways.
P-16.2.8 - Hydroxyapatite-hybridized Double-network Hydrogel Recruits Mesenchymal Stem Cells and Differentiates Them to Osteogenic Cells
P-16.2.9 - Bioactive and Electroactive Polymer-Based Scaffold System for Integrative Cartilage Repair
P-16.3.1 - Anatomic Factors Associated with Osteochondral Allograft Matching for Trochlear Cartilage Defects
P-16.3.5 - The Application of Particulated Juvenile Allograft Cartilage for the Repair of Porcine Articular Cartilage Defects
P-18.1.1 - No Sex Influence on Cartilage Surgery Outcome: Analysis at Long-term Follow-up
P-18.1.9 - 25-Year Function after Proximal Tibial Osteotomy: Paired Outcomes of Bilateral TKAs Following Unilateral Osteotomy
P-18.2.8 - Biomimetic Osteochondral Scaffold for the Treatment of Osteochondritis Dissecans of the Knee: Stable Results at 12 Years Follow-up.
P-18.2.9 - Patellofemoral Cartilage Lesions Treated with a Hyaluronan-based MACT Technique: Results at >15 years’ follow-up
P-18.3.2 - Evaluation of the Effect of Celecoxib on Cartilage in Vitro and in a Rat Osteoarthritis Model